Distribution patterns of tau pathology in progressive supranuclear palsy

被引:0
作者
Gabor G. Kovacs
Milica Jecmenica Lukic
David J. Irwin
Thomas Arzberger
Gesine Respondek
Edward B. Lee
David Coughlin
Armin Giese
Murray Grossman
Carolin Kurz
Corey T. McMillan
Ellen Gelpi
Yaroslau Compta
John C. van Swieten
Laura Donker Laat
Claire Troakes
Safa Al-Sarraj
John L. Robinson
Sigrun Roeber
Sharon X. Xie
Virginia M.- Y. Lee
John Q. Trojanowski
Günter U. Höglinger
机构
[1] University of Pennsylvania,Center for Neurodegenerative Disease Research (CNDR), Institute On Aging and Department of Pathology & Laboratory Medicine
[2] University of Toronto,Tanz Centre for Research in Neurodegenerative Disease (CRND) and Department of Laboratory Medicine and Pathobiology
[3] University Health Network,Laboratory Medicine Program and Krembil Brain Institute
[4] German Center for Neurodegenerative Diseases (DZNE),Clinic of Neurology
[5] CCS,Department of Neurology
[6] University of Belgrade,Department of Psychiatry and Psychotherapy
[7] University of Pennsylvania,Center for Neuropathology and Prion Research
[8] University Hospital,Department of Neurology, Klinikum Rechts der Isar
[9] LMU Munich,Frontotemporal Degeneration Center
[10] LMU Munich,Neurological Tissue Bank and Neurology Department, Hospital Clínic de Barcelona
[11] Munich Cluster for Systems Neurology (SyNergy),Parkinson’s Disease & Movement Disorders Unit, Hospital Clínic / IDIBAPS / CIBERNED (CB06/05/0018
[12] Technical University of Munich,ISCIII) / European Reference Network for Rare Neurological Diseases (ERN
[13] University of Pennsylvania,RND) / Institut de Neurociències (Maria de Maeztu Center)
[14] Universitat de Barcelona,Department of Neurology
[15] IDIBAPS,Department Clinical Genetics
[16] CERCA,London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience
[17] Universitat de Barcelona,Department of Biostatistics, Epidemiology and Informatics
[18] Erasmus Medical Centre,Department of Neurology
[19] Erasmus Medical Center,Department of Neurosciences
[20] Kings College London,Institute of Neurology
[21] University of Pennsylvania,undefined
[22] Hannover Medical School,undefined
[23] University of California,undefined
[24] Medical University of Vienna,undefined
来源
Acta Neuropathologica | 2020年 / 140卷
关键词
Coiled body; Neurofibrillary tangle; Progressive supranuclear palsy; Propagation; Richardson syndrome; Sequential involvement; Stage; Tau; Tauopathy; Tufted astrocyte;
D O I
暂无
中图分类号
学科分类号
摘要
Progressive supranuclear palsy (PSP) is a 4R-tauopathy predominated by subcortical pathology in neurons, astrocytes, and oligodendroglia associated with various clinical phenotypes. In the present international study, we addressed the question of whether or not sequential distribution patterns can be recognized for PSP pathology. We evaluated heat maps and distribution patterns of neuronal, astroglial, and oligodendroglial tau pathologies and their combinations in different clinical subtypes of PSP in postmortem brains. We used conditional probability and logistic regression to model the sequential distribution of tau pathologies across different brain regions. Tau pathology uniformly predominates in the neurons of the pallido-nigro-luysian axis in different clinical subtypes. However, clinical subtypes are distinguished not only by total tau load but rather cell-type (neuronal versus glial) specific vulnerability patterns of brain regions suggesting distinct dynamics or circuit-specific segregation of propagation of tau pathologies. For Richardson syndrome (n = 81) we recognize six sequential steps of involvement of brain regions by the combination of cellular tau pathologies. This is translated to six stages for the practical neuropathological diagnosis by the evaluation of the subthalamic nucleus, globus pallidus, striatum, cerebellum with dentate nucleus, and frontal and occipital cortices. This system can be applied to further clinical subtypes by emphasizing whether they show caudal (cerebellum/dentate nucleus) or rostral (cortical) predominant, or both types of pattern. Defining cell-specific stages of tau pathology helps to identify preclinical or early-stage cases for the better understanding of early pathogenic events, has implications for understanding the clinical subtype-specific dynamics of disease-propagation, and informs tau-neuroimaging on distribution patterns.
引用
收藏
页码:99 / 119
页数:20
相关论文
共 245 条
  • [31] Jacobson S(2019)Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies Mov Disord 29 1758-918
  • [32] Evidente VG(2014)The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases Mov Disord 141 2181-1662
  • [33] Adler CH(2018)Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated Brain 180 101644-81
  • [34] Sabbagh MN(2019)Four-repeat tauopathies Prog Neurobiol 63 911-490
  • [35] Connor DJ(2004)Staging of argyrophilic grains: an age-associated tauopathy J Neuropathol Exp Neurol 34 1655-634
  • [36] Hentz JG(2019)Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy Mov Disord 31 77-93
  • [37] Caviness JN(2019)Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy Mov Disord 259 482-151
  • [38] Forrest SL(2011)Early-stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra Neuropathology 82 622-128
  • [39] Kril JJ(2012)The relationship between clinical and pathological variables in Richardson's syndrome J Neurol 66 87-988
  • [40] Halliday GM(2017)(18) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study Ann Neurol 133 149-1545